Clinical Trial

A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a Phase III, randomized, open-label, active-controlled study to evaluate the safety and efficacy of AND017 in non-dialysis-dependent (NDD)-CKD patients compared with the active control, ESA treatment
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-03-17; most recent amendment 2026-03-24.
Trial Details
NCT Number NCT07487727
Lead Sponsor Kind Pharmaceuticals LLC
Conditions Anemia Due to Chronic Kidney Disease
Enrollment 240 participants
Start Date 2025-12-03
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-27